Olmesartan lactone,
Olmesartan Lactone Impurity,
849206-43-5,
UNII-CML390S782,
Olmesartan medoxomil related compound A,
CML390S782,
6,6-Dimethyl-2-propyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-3,6-dihydro-4H-furo(3,4-d)imidazol-4-one,
6,6-Dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one,
Olmesartan medoxomil impurity B [EP],
Olmesartan medoxomil related compound A [USP],
Olmesartan medoxomil related compound A RS [USP],
DTXSID90233966,
ZINC77312058,
ACN-026594,
4H-Furo(3,4-d)imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,
FT-0673277,
3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Furo[3,4-d]imidazol-4-one,
4,4-dimethyl-2-propyl-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]furo[4,3-d]imidazol-6-one,
6,6-dimethyl-2-propyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]furo[3,4-d]imidazol-4-one,
Olmesartan Medoxomil EP Impurity B,
CS-T-38010,